NASDAQ:BHSE Bull Horn (BHSE) Stock Price, News & Analysis → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free BHSE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$9.93▼$10.0152-Week Range N/AVolume1.18 million shsAverage Volume68,771 shsMarket Capitalization$61.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Bull Horn alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About Bull HornBull Horn Holdings Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the sports, entertainment, and brands sectors. The company was incorporated in 2018 and is based in Miami Beach, Florida.Read More Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. BHSE Stock News HeadlinesJanuary 10, 2023 | newsweek.comOwner Captures Bull Terrier's Hilarious Reaction to Playing 'Hide and Seek'October 29, 2022 | msn.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.59%May 10, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.October 27, 2022 | seekingalpha.comSPAC Bull Horn shareholders approve merger with biotech Coeptis TherapeuticsSeptember 30, 2022 | bizjournals.comCoeptis' opportunities expand with licensing deal for Pitt technologyJuly 6, 2022 | uk.finance.yahoo.comBull Horn Holdings Corp. (BHSE)May 9, 2022 | news.yahoo.comSports SPAC’s Pivot to Pharma Reflects Blank-Check Market HeadwindsMay 6, 2022 | finance.yahoo.comLEGENDARY GLOBAL FOOTBALL STAR RONALDINHO JOINS EXPANSION TEAM OWNERSHIP GROUP IN MAJOR ARENA SOCCER LEAGUEMay 10, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.April 20, 2022 | finance.yahoo.comCancer-Focused Coeptis Therapeutics Turns To SPAC Deal To Uplist To NASDAQApril 19, 2022 | apnews.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ACC, CMPI, BHSEApril 19, 2022 | seekingalpha.comCoeptis Therapeutics agrees to go public through deal with SPAC Bull Horn HoldingsApril 19, 2022 | seekingalpha.comCoeptis Therapeutics to merge with SPAC Bull Horn, uplist to NasdaqApril 19, 2022 | nasdaq.comBull Horn Strikes $175-mln Merger Deal With Coeptis To Form Coeptis Therapeutics HoldingsJanuary 15, 2022 | seekingalpha.comEsports startup RekTGlobal is said in talks to go public through Baron Davis-backed SPACJanuary 14, 2022 | finance.yahoo.comBaron Davis SPAC In Talks With ESports Startup ReKTGlobalDecember 3, 2021 | msn.comToronto Blue Jays, Denver Broncos And More Sports Teams Could Be For Sale: Will A SPAC Land A Deal?See More Headlines Receive BHSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bull Horn and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:BHSE CUSIPN/A CIK1759186 Webwww.bullhornse.com Phone305-671-3341FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$15.23 million Net MarginsN/A Pretax MarginN/A Return on Equity-119.46% Return on Assets9.08% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow7.36 Book Value($0.72) per share Price / BookN/AMiscellaneous Outstanding Shares5,120,000Free Float3,244,000Market Cap$61.14 million OptionableNot Optionable Beta-0.01 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Robert Striar (Age 46)CEO & Director Mr. Christopher J. Calise (Age 45)CFO & Director Key CompetitorsCidara TherapeuticsNASDAQ:CDTXEntera BioNASDAQ:ENTXGenenta ScienceNASDAQ:GNTALENZ TherapeuticsNASDAQ:LENZAligos TherapeuticsNASDAQ:ALGSView All Competitors This page (NASDAQ:BHSE) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bull Horn Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
